We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
AUM
$230M
AUM Growth
-$12.3M
Cap. Flow
-$21.2M
Cap. Flow %
-9.21%
Top 10 Hldgs %
41.59%
Holding
122
New
32
Increased
19
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$2.41M
2
GM icon
General Motors
GM
+$2.39M
3
ABBV icon
AbbVie
ABBV
+$2.25M
4
CVS icon
CVS Health
CVS
+$1.57M
5
LLY icon
Eli Lilly
LLY
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 35.26%
2 Technology 14.96%
3 Communication Services 9.7%
4 Financials 5.34%
5 Consumer Discretionary 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
51
Qualcomm
QCOM
$155B
$994K 0.43%
7,500
+5,000
+200% +$721K
TGT icon
52
Target
TGT
$65.6B
$990K 0.43%
5,000
BOX icon
53
Box
BOX
$4.37B
$918K 0.4%
40,000
IBM icon
54
IBM
IBM
$211B
$866K 0.38%
+6,799
New +$814K
MRVL icon
55
Marvell Technology
MRVL
$168B
$857K 0.37%
+17,500
New +$858K
JNJ icon
56
Johnson & Johnson
JNJ
$618B
$822K 0.36%
5,000
ABBV icon
57
CALL
AbbVie
ABBV
$443B
$812K 0.35%
+7,500
New +$802K
ITW icon
58
Illinois Tool Works
ITW
$82.6B
$775K 0.34%
+3,500
New +$727K
ADMS
59
DELISTED
Adamas Pharmaceuticals
ADMS
$768K 0.33%
160,000
+128,764
+412% +$672K
IBB icon
60
CALL
iShares Biotechnology ETF
IBB
$9.34B
$753K 0.33%
+5,000
New +$794K
AAPL icon
61
Apple
AAPL
$4.54T
$733K 0.32%
6,000
-500
-8% -$64.2K
VZ icon
62
CALL
Verizon
VZ
$195B
$727K 0.32%
+12,500
New +$705K
NXPI icon
63
NXP Semiconductors
NXPI
$57.8B
$705K 0.31%
3,500
NOK icon
64
Nokia
NOK
$51B
$669K 0.29%
169,000
-121,000
-42% -$505K
GILD icon
65
PUT
Gilead Sciences
GILD
$162B
$646K 0.28%
+10,000
New +$645K
GEN icon
66
Gen Digital
GEN
$16.4B
$638K 0.28%
30,000
NKTR icon
67
Nektar Therapeutics
NKTR
$2.39B
$626K 0.27%
2,087
AAPL icon
68
CALL
Apple
AAPL
$4.54T
$611K 0.27%
+5,000
New +$642K
BDX icon
69
CALL
Becton Dickinson
BDX
$45.6B
$608K 0.26%
+2,563
New +$626K
KSS icon
70
Kohl's
KSS
$2.17B
$596K 0.26%
10,000
KYNB
71
Kyntra Bio
KYNB
$27.2M
$594K 0.26%
685
-555
-45% -$591K
AMD icon
72
CALL
Advanced Micro Devices
AMD
$776B
$589K 0.26%
+7,500
New +$646K
MSFT icon
73
Microsoft
MSFT
$3.45T
$589K 0.26%
2,500
BABA icon
74
CALL
Alibaba
BABA
$293B
$567K 0.25%
2,500
+1,000
+67% +$246K
SPCE icon
75
Virgin Galactic
SPCE
$328M
$567K 0.25%
925
-825
-47% -$621K

Similar funds

DCF Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, DCF Advisers held 122 positions worth $230M, down 5.1% from $242M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

DCF Advisers withdrew a net $21.2M in Q1 2021, closing 19 positions and reducing 29 holdings. Its most notable exit was Intel, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in CVS Health worth $1.62M.

  • DCF Advisers's largest Q1 2021 buy was CVS Health: 21,500 shares worth $1.62M.
  • DCF Advisers added most to Verizon in Q1 2021, an estimated $2.41M increase.
  • DCF Advisers's biggest Q1 2021 reduction was SPDR Gold Trust, cutting an estimated $3.11M.
  • DCF Advisers fully exited Intel in Q1 2021, selling an estimated $2.44M.
  • DCF Advisers's ten largest holdings make up 42% of its $230M portfolio in Q1 2021.
  • DCF Advisers opened 32 new positions and closed 19 in Q1 2021.
  • DCF Advisers's portfolio value fell 5.1% quarter-over-quarter to $230M.

Based on DCF Advisers's 13F filing for Q1 2021, filed 12 May 2021.